HUB Investment Partners LLC Reduces Position in Intuitive Surgical, Inc. $ISRG

HUB Investment Partners LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,043 shares of the medical equipment provider’s stock after selling 8,219 shares during the quarter. Intuitive Surgical comprises approximately 0.8% of HUB Investment Partners LLC’s portfolio, making the stock its 22nd biggest holding. HUB Investment Partners LLC’s holdings in Intuitive Surgical were worth $23,275,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the business. Intellectus Partners LLC lifted its stake in shares of Intuitive Surgical by 33.2% during the 3rd quarter. Intellectus Partners LLC now owns 6,055 shares of the medical equipment provider’s stock valued at $2,708,000 after buying an additional 1,510 shares in the last quarter. Gabelli Funds LLC grew its stake in Intuitive Surgical by 7.2% in the 3rd quarter. Gabelli Funds LLC now owns 70,480 shares of the medical equipment provider’s stock valued at $31,521,000 after buying an additional 4,755 shares in the last quarter. Gamco Investors INC. ET AL raised its holdings in Intuitive Surgical by 1.5% during the 3rd quarter. Gamco Investors INC. ET AL now owns 10,595 shares of the medical equipment provider’s stock valued at $4,738,000 after acquiring an additional 152 shares during the period. Aptus Capital Advisors LLC raised its holdings in Intuitive Surgical by 8.7% during the 3rd quarter. Aptus Capital Advisors LLC now owns 58,028 shares of the medical equipment provider’s stock valued at $25,952,000 after acquiring an additional 4,649 shares during the period. Finally, Integrity Advisory Solutions LLC purchased a new stake in shares of Intuitive Surgical during the third quarter worth $369,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Argus cut their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Barclays set a $712.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. Piper Sandler reiterated an “overweight” rating and set a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. Finally, Royal Bank Of Canada upped their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Insider Buying and Selling at Intuitive Surgical

In other news, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $531.52, for a total value of $1,488,256.00. Following the completion of the transaction, the director owned 15,720 shares in the company, valued at approximately $8,355,494.40. This represents a 15.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 37,261 shares of company stock valued at $19,690,721. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $490.16 on Friday. The stock has a market capitalization of $174.07 billion, a P/E ratio of 62.12, a PEG ratio of 3.83 and a beta of 1.66. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88. The firm’s 50 day simple moving average is $521.64 and its two-hundred day simple moving average is $512.05.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.21 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.